旧法与新医学相遇:重新审视刑事被告人非自愿精神药物。

IF 0.7 4区 社会学 Q2 LAW Wisconsin Law Review Pub Date : 2001-09-18 DOI:10.2139/SSRN.283317
D. Siegel, A. Grudzinskas, D. Pinals
{"title":"旧法与新医学相遇:重新审视刑事被告人非自愿精神药物。","authors":"D. Siegel, A. Grudzinskas, D. Pinals","doi":"10.2139/SSRN.283317","DOIUrl":null,"url":null,"abstract":"The law concerning when a criminal defendant can be subjected to involuntary psychotropic medication prior to trial relies upon two distinct paradigms: a parens patriae-based treatment rationale and an institutional security rationale. These distinctions have created an unclear jurisprudence, which has left unanswered the basic questions: when can involuntary medication of the criminal defendant occur, and what procedure must be followed in order to undertake such medication? The existing jurisprudence was based upon two implicit premises concerning the practice of involuntary medication: it was very rare, and it was accompanied by numerous severe physiological and mental risks. Deinstitutionalization of the mentally ill, changes in treatment methodologies, and the development of new drugs, however, are rapidly undermining both these premises. These changes highlight the shortcomings in the law. Moreover, they demand that a jurisprudence be recognized which clearly reflects the range of constitutional interests implicated by involuntary medication of the criminal defendant prior to trial, particularly those interests implicated by his trial-related constitutional rights. We would reformulate the analysis to include an initial determination of the defendant's competence to make treatment decisions. We argue that the jurisprudence should then require that the government demonstrate both a compelling interest in psychotropically medicating the defendant, and that medication is medically appropriate and the most narrowly tailored, least intrusive means of achieving that interest, and that whenever such a showing is made appropriate safeguards be implemented to protect the defendant's trial-related rights. We also argue that establishing competence to stand trial, alone, may constitute such a compelling interest. Procedurally, we argue that this showing should be made before a trial judge (rather than hospital administrators or doctors), after a full hearing, at which the defendant is afforded the rights to notice, counsel, confrontation, and cross-examination, and that the government should satisfy its burden through clear and convincing proof.","PeriodicalId":54350,"journal":{"name":"Wisconsin Law Review","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2001-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Old law meets new medicine: revisiting involuntary psychotropic medication of the criminal defendant.\",\"authors\":\"D. Siegel, A. Grudzinskas, D. Pinals\",\"doi\":\"10.2139/SSRN.283317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The law concerning when a criminal defendant can be subjected to involuntary psychotropic medication prior to trial relies upon two distinct paradigms: a parens patriae-based treatment rationale and an institutional security rationale. These distinctions have created an unclear jurisprudence, which has left unanswered the basic questions: when can involuntary medication of the criminal defendant occur, and what procedure must be followed in order to undertake such medication? The existing jurisprudence was based upon two implicit premises concerning the practice of involuntary medication: it was very rare, and it was accompanied by numerous severe physiological and mental risks. Deinstitutionalization of the mentally ill, changes in treatment methodologies, and the development of new drugs, however, are rapidly undermining both these premises. These changes highlight the shortcomings in the law. Moreover, they demand that a jurisprudence be recognized which clearly reflects the range of constitutional interests implicated by involuntary medication of the criminal defendant prior to trial, particularly those interests implicated by his trial-related constitutional rights. We would reformulate the analysis to include an initial determination of the defendant's competence to make treatment decisions. We argue that the jurisprudence should then require that the government demonstrate both a compelling interest in psychotropically medicating the defendant, and that medication is medically appropriate and the most narrowly tailored, least intrusive means of achieving that interest, and that whenever such a showing is made appropriate safeguards be implemented to protect the defendant's trial-related rights. We also argue that establishing competence to stand trial, alone, may constitute such a compelling interest. Procedurally, we argue that this showing should be made before a trial judge (rather than hospital administrators or doctors), after a full hearing, at which the defendant is afforded the rights to notice, counsel, confrontation, and cross-examination, and that the government should satisfy its burden through clear and convincing proof.\",\"PeriodicalId\":54350,\"journal\":{\"name\":\"Wisconsin Law Review\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2001-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Wisconsin Law Review\",\"FirstCategoryId\":\"90\",\"ListUrlMain\":\"https://doi.org/10.2139/SSRN.283317\",\"RegionNum\":4,\"RegionCategory\":\"社会学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wisconsin Law Review","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.2139/SSRN.283317","RegionNum":4,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"LAW","Score":null,"Total":0}
引用次数: 4

摘要

关于刑事被告何时可以在审判前接受非自愿精神药物治疗的法律依赖于两种截然不同的范例:基于父母的治疗理由和机构安全理由。这些区别造成了一种不明确的法理学,这使得一些基本问题没有得到解答:刑事被告什么时候可以进行非自愿的药物治疗,以及必须遵循什么程序才能进行这种药物治疗?关于非自愿用药的做法,现有的法理学基于两个隐含的前提:这种做法非常罕见,并且伴随着许多严重的生理和精神风险。然而,精神病患者的去机构化、治疗方法的改变以及新药的开发正在迅速破坏这两个前提。这些变化突出了法律的缺陷。此外,他们要求承认一种明确反映刑事被告在审判前非自愿用药所涉及的宪法利益范围的法理,特别是与审判有关的宪法权利所涉及的利益。我们将重新制定分析,包括对被告作出治疗决定的能力的初步确定。我们认为,法理应要求政府既要证明对被告进行精神药物治疗有令人信服的兴趣,又要证明药物治疗在医学上是适当的,是实现这一兴趣的最狭隘、最不具侵入性的手段,而且无论何时,只要证明了这一点,就应实施适当的保障措施,以保护被告的与审判有关的权利。我们还认为,单独确立受审能力可能构成如此引人注目的利益。在程序上,我们认为,这种证明应该在审判法官(而不是医院管理人员或医生)面前进行,在充分的听证会之后,被告被赋予通知权、律师权、对质权和质证权,政府应该通过明确和令人信服的证据来履行其责任。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Old law meets new medicine: revisiting involuntary psychotropic medication of the criminal defendant.
The law concerning when a criminal defendant can be subjected to involuntary psychotropic medication prior to trial relies upon two distinct paradigms: a parens patriae-based treatment rationale and an institutional security rationale. These distinctions have created an unclear jurisprudence, which has left unanswered the basic questions: when can involuntary medication of the criminal defendant occur, and what procedure must be followed in order to undertake such medication? The existing jurisprudence was based upon two implicit premises concerning the practice of involuntary medication: it was very rare, and it was accompanied by numerous severe physiological and mental risks. Deinstitutionalization of the mentally ill, changes in treatment methodologies, and the development of new drugs, however, are rapidly undermining both these premises. These changes highlight the shortcomings in the law. Moreover, they demand that a jurisprudence be recognized which clearly reflects the range of constitutional interests implicated by involuntary medication of the criminal defendant prior to trial, particularly those interests implicated by his trial-related constitutional rights. We would reformulate the analysis to include an initial determination of the defendant's competence to make treatment decisions. We argue that the jurisprudence should then require that the government demonstrate both a compelling interest in psychotropically medicating the defendant, and that medication is medically appropriate and the most narrowly tailored, least intrusive means of achieving that interest, and that whenever such a showing is made appropriate safeguards be implemented to protect the defendant's trial-related rights. We also argue that establishing competence to stand trial, alone, may constitute such a compelling interest. Procedurally, we argue that this showing should be made before a trial judge (rather than hospital administrators or doctors), after a full hearing, at which the defendant is afforded the rights to notice, counsel, confrontation, and cross-examination, and that the government should satisfy its burden through clear and convincing proof.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Wisconsin Law Review
Wisconsin Law Review Social Sciences-Law
CiteScore
1.00
自引率
16.70%
发文量
0
期刊介绍: The Wisconsin Law Review is a student-run journal of legal analysis and commentary that is used by professors, judges, practitioners, and others researching contemporary legal topics. The Wisconsin Law Review, which is published six times each year, includes professional and student articles, with content spanning local, state, national, and international topics. In addition to publishing the print journal, the Wisconsin Law Review publishes the Wisconsin Law Review Forward and sponsors an annual symposium at which leading scholars debate a significant issue in contemporary law.
期刊最新文献
The October 2021 Term and the Challenge to Progressive Constitutional Theory Debunking the Stranger in the Bushes Myth: The Case for Sexual Assault Protection Orders (Mis)use of State Law in Bankruptcy: The Hanging Paragraph Story Readings in the economics of contract law: Price adjustment in long-term contracts Educating Lawyers for Community
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1